Bio Green Med Solution, Inc.
BGMSIndustrialsNASDAQBuilding Products & Equipment
Scan Results
Daily timeframeBio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. At a $6.4M market cap, Bio Green Med Solution, Inc. ranks as a micro-cap company within industrials. It is also involved in research and development of pharmaceuticals.
Market Cap
$6.4M
Beta
-0.38
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-5.02
EPS (Fwd)
—
ROE
34.4%
ROA
-37.0%
Cash
$3.8M
Total Debt
$0
Free CF
-$3.7M
52W Change
-50.8%
Annual Financials
Cash vs Debt
Where BGMS stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, BGMS finished 1.06% below its 150-day moving average ($0.94) and 6.06% below its 200-day moving average ($0.99). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is BGMS overbought or oversold?
At the October 20, 2026 close, BGMS's RSI(14) was 54.7, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Bio Green Med Solution, Inc. reports $3.8M in cash and $0 in total debt. Free cash flow is running at -$3.7M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of 34.4% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity.
The relatively low beta of -0.38 suggests BGMS is a less volatile holding compared to the broader index. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Bio Green Med Solution, Inc.'s trajectory.